Pharma Stocks
-
Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Ind…
Current Price and Market Context As of 12 Feb 2026, Gland Pharma’s stock closed at ₹1,874.00, down 0.51% from the…
Read More » -
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
Universe Pharmaceuticals INC. Ji’an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or…
Read More » -
Royalty Pharma Q4 Earnings Call Highlights
Royalty Pharma logo Royalty Pharma called 2025 a “landmark year,” delivering double‑digit growth in portfolio and royalty receipts, finishing slightly…
Read More » -
We Think Herantis Pharma Oyj (HEL:HRTIS) Needs To Drive Business Growth Carefully
There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration…
Read More » -
Loss-Making Island Pharmaceuticals Limited (ASX:ILA) Expected To Breakeven In The Medium-Term
We feel now is a pretty good time to analyse Island Pharmaceuticals Limited’s (ASX:ILA) business as it appears the company…
Read More » -
Avadel Pharma court-clears Alkermes takeover plan
Avadel Pharmaceuticals (Nasdaq: AVDL) announced that the Irish High Court sanctioned, without modification, the scheme…
Read More » -
February 10: Japan Biotech Surge in PTS Puts Kubota Pharma on Watch
Japan biotech stocks are in focus after strong PTS moves overnight. Rena jumped on clinical trial news tied to Saudi…
Read More » -
Aurobindo Pharma Sees Sharp Open Interest Surge Amidst We…
Open Interest and Volume Dynamics The open interest (OI) in Aurobindo Pharma’s futures and options contracts jumped from 53,826 to…
Read More » -
What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings
Healthcare royalties company Royalty Pharma (NASDAQ: RPRX) will be reporting results this Wednesday morning. Here’s what to expect. Royalty Pharma…
Read More » -
SpyGlass Pharma closes $172.5M Nasdaq IPO
SpyGlass Pharma (Nasdaq: SGP) closed its initial public offering of 10,781,250 shares, including full exercise…
Read More »